LSF inhibitor / Inhibitor of transcription factor LSF specifically targeting its DNA binding and corresponding transcriptional activity (IC50=2.1 uM). Rapidly induces apoptosis in an aggressive hepatocellular carcinoma (HCC) cell line and dramatically inhibits tumor growth in a mouse xenograft model with no general tissue cytotoxicity.1,2 In human HCC cells, FQI1 induced mitotic arrest with an accompanying increase in cyclin B1.3 Blocks LSF-stimulated activation of DNA methyltransferase 1.4 Cell permeable.
Biochemicals & reagents
599151-35-6
1) Grant et al. (2012), Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma; Proc. Natl. Acad. Sci. USA, 109 4503 2) Santhekadur et al. (2012), The transcription factor LSF: a novel oncogene for hepatocellular carcinoma; Am. J. Cancer Res., 2 269 3) Raiasekaran et al. (2015), Small molecule inhibitors of Late SV40 Factor (LSF) abrogate hepatocellular carcinoma (HCC): Evaluation using an endogenous HCC model; Oncotarget 6 26266 4) Chin et al. (2016), Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression; Oncotarget, 7 83627
-20°C
TARGET: Transcription factor -- PATHWAY: Transcription; Apoptosis inducer; Cell cycle -- RESEARCH AREA: Cell death -- DISEASE AREA: Cancer